What are the recommended dosing guidelines for citalopram?

Citalopram Dosing Guidelines

Start citalopram at 20 mg once daily, which is the recommended initial and target dose for most adults, with a maximum of 40 mg/day in patients under 60 years of age. 1

Standard Dosing by Age

Adults Under 60 Years

• Initial dose: 10-20 mg once daily 2
• Target dose: 20 mg/day (minimum effective dose) 1, 3, 4
• Maximum dose: 40 mg/day 1
• Titration: Can increase after 1 week if needed, though 20 mg is effective for most patients 5, 3

Adults Over 60 Years

• Initial dose: 10 mg once daily 2
• Maximum dose: 20 mg/day 1
• This reduced maximum is mandatory due to increased risk of QT prolongation from age-related pharmacokinetic changes (30-50% increased AUC and half-life) 1

Special Population Dosing

Hepatic Impairment

• Maximum dose: 20 mg/day 1
• Oral clearance reduced by 37% and half-life doubled in hepatically impaired patients 1

CYP2C19 Poor Metabolizers

• Maximum dose: 20 mg/day 1
• These patients show 68% increased Cmax and 107% increased AUC 1

Patients Taking CYP2C19 Inhibitors

• Maximum dose: 20 mg/day when taking cimetidine or other CYP2C19 inhibitors 1
• This restriction applies due to QT prolongation risk 1

Renal Impairment

• Mild to moderate: No dose adjustment needed (only 17% reduction in clearance) 1
• Severe (CrCl <20 mL/min): No data available; use caution 1

Clinical Considerations

The 20 mg dose represents the minimum effective dose based on meta-analysis of nine placebo-controlled trials 3, 4. The dose-response curve is remarkably flat between 20-60 mg, meaning higher doses provide minimal additional benefit for most patients 4.

When to Consider 40 mg (in patients <60 years only):

• Severe depression 3, 4
• Recurrent depression 3
• Inadequate response after 3-4 weeks at 20 mg 5

Timing and Administration

• Can be taken morning or evening 2
• Food does not affect absorption 1
• Peak levels occur at approximately 4 hours 1
• Steady state achieved in approximately 1 week 1

Critical Safety Warnings

QT prolongation is the primary dose-limiting toxicity. Citalopram causes dose-dependent QT prolongation with risk of Torsade de Pointes, ventricular tachycardia, and sudden death at doses exceeding 40 mg/day 6. This is why the FDA mandates maximum doses of 40 mg for adults <60 years and 20 mg for those ≥60 years 1.

Contraindicated Combinations:

• MAOIs: Absolute contraindication due to serotonin syndrome risk 1
• Drugs prolonging QT interval: Use extreme caution 6
• Pimozide: Increases QTc by ~10 msec 1

Drug Interactions Requiring Dose Reduction to 20 mg:

• Cimetidine (increases citalopram AUC by 43%) 1
• Other CYP2C19 inhibitors (e.g., omeprazole) 1

Real-World Prescribing Data

Following 2011 regulatory warnings, high-dose prescribing declined dramatically: 64.8% reduction in patients <65 years and 33.6% in those ≥65 years 7. However, adherence remains suboptimal in elderly patients (23% still receive >20 mg) and regarding drug-drug interactions 7, 8.

Common pitfall: The elderly are frequently prescribed doses exceeding 20 mg despite clear contraindications 7, 8. Always verify age and reduce to maximum 20 mg in patients over 60 years.

Discontinuation

Taper over 10-14 days to minimize discontinuation syndrome (dizziness, nausea, paresthesias, anxiety) 2. While less problematic than paroxetine, abrupt cessation can still cause withdrawal symptoms 6.